RPL23AP7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.075200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.661980E-01
Normal-vs-Stage2
5.843000E-01
Normal-vs-Stage3
5.914800E-01
Normal-vs-Stage4
6.827200E-01
Stage1-vs-Stage2
3.158000E-01
Stage1-vs-Stage3
7.964800E-01
Stage1-vs-Stage4
3.593600E-02
Stage2-vs-Stage3
6.507800E-01
Stage2-vs-Stage4
3.201200E-01
Stage3-vs-Stage4
3.839000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.239800E-01
Normal-vs-AfricanAmerican
7.866100E-02
Normal-vs-Asian
2.096600E-01
Caucasian-vs-AfricanAmerican
8.119900E-02
Caucasian-vs-Asian
2.612000E-01
AfricanAmerican-vs-Asian
3.173800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.240600E-01
Normal-vs-Female
7.330000E-01
Male-vs-Female
2.288000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.118400E-02
Normal-vs-Age(41-60Yrs)
6.748000E-01
Normal-vs-Age(61-80Yrs)
5.834200E-01
Normal-vs-Age(81-100Yrs)
9.546600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.645420E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.724000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.836000E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.417600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.854000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.278800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.264400E-01
Normal-vs-Daily Drinker
2.088800E-01
Normal-vs-Weekly Drinker
8.947600E-01
Normal-vs-Occasional Drinker
9.421000E-01
Normal-vs-Social Drinker
6.344600E-01
Non Drinker-vs-Daily Drinker
1.313160E-01
Non Drinker-vs-Weekly Drinker
5.203200E-01
Non Drinker-vs-Occasional Drinker
8.004000E-01
Non Drinker-vs-Social Drinker
6.506000E-01
Daily Drinker-vs-Weekly Drinker
3.187800E-02
Daily Drinker-vs-Occasional Drinker
1.653610E-01
Daily Drinker-vs-Social Drinker
4.184800E-01
Weekly Drinker-vs-Occasional Drinker
7.428000E-01
Weekly Drinker-vs-Social Drinker
3.126800E-01
Occasional Drinker-vs-Social Drinker
5.499200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.910600E-01
Normal-vs-Grade 2
9.654200E-01
Normal-vs-Grade 3
9.047600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.879000E-03
Grade 1-vs-Grade 3
3.395600E-02
Grade 1-vs-Grade 4
7.910600E-01
Grade 2-vs-Grade 3
9.862800E-01
Grade 2-vs-Grade 4
9.654200E-01
Grade 3-vs-Grade 4
9.047600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.701200E-01
Normal-vs-NonDiabetic
6.443600E-01
Diabetic-vs-NonDiabetic
9.366600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.757800E-01
Normal-vs-NoPancreatitis
6.633800E-01
Pancreatitis-vs-NoPancreatitis
6.694200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.496200E-01
Normal-vs-N1
6.185200E-01
N0-vs-N1
8.121400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.226800E-01
Normal-vs-TP53-NonMutant
4.016200E-01
TP53-Mutant-vs-TP53-NonMutant
2.389000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
